Hospital
Northwest Hospital Center, INC.
Northwest Hospital Center, INC. was paid $3.17M by Medicaid between Jan 2018 and Dec 2024, across 95 billing codes. Its largest line is G0378, Hospital observation service, per hour — 36% of everything it billed.
33Billing provider infoNORTHWEST HOSPITAL CENTER, INC.
RANDALLSTOWN, MD 21133
RANDALLSTOWN, MD 21133
33aNPI1487695888assigned 06/09/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.17M
24GClaims127,147
24DCodes billed95
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Maryland
Rank by total paid#17 of 69
Median peer was paid$870K
This provider vs. median3.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25,528 | $102K | |
| 2019 | 21,200 | $325K | |
| 2020 | 14,665 | $526K | |
| 2021 | 16,143 | $549K | |
| 2022 | 17,225 | $647K | |
| 2023 | 18,520 | $697K | |
| 2024incomplete | 13,866 | $323K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0378 | Hospital observation service, per hour | 36% | 3,855 | 3,276 | $1.15M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 25% | 7,062 | 6,442 | $784K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 5,763 | 5,281 | $537K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 9.8% | 5,095 | 3,324 | $311K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 7.9% | 3,511 | 3,114 | $250K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.1% | 362 | 253 | $35K |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | <1% | 98 | 93 | $20K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 344 | 309 | $14K |
| 86850 | <1% | 328 | 293 | $9K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 2,889 | 2,512 | $8K |
| 80053 | Comprehensive metabolic panel | <1% | 12,598 | 10,220 | $7K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,018 | 2,925 | $6K |
83 more codes
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 51 | $5K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,991 | $4K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 722 | $4K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 187 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,002 | $3K |
| 11043 | <1% | 19 | $2K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 190 | $2K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 3,094 | $2K |
| 84484 | <1% | 6,452 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 3,059 | $2K |
| 85027 | <1% | 9,970 | $2K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 510 | $1K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,319 | $1K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 119 | $956.82 |
| 87088 | <1% | 1,867 | $757.81 | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 137 | $738.21 |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 661 | $726.41 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,433 | $719.42 |
| 81001 | <1% | 6,790 | $656.02 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 68 | $523.65 |
| 87040 | <1% | 458 | $441.98 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 500 | $369.66 |
| 83605 | <1% | 2,947 | $340.80 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,662 | $310.93 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 271 | $242.07 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,647 | $239.73 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,285 | $222.80 |
| 83880 | <1% | 1,279 | $194.47 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 555 | $163.63 |
| 93971 | <1% | 57 | $159.20 | |
| 84703 | <1% | 905 | $146.83 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 408 | $122.29 |
| 83690 | <1% | 2,448 | $119.50 | |
| 85610 | <1% | 2,123 | $114.08 | |
| 87186 | <1% | 389 | $100.07 | |
| 83735 | <1% | 4,162 | $88.22 | |
| 85730 | <1% | 285 | $68.84 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 165 | $68.16 |
| E1352 | Oxygen accessory, flow regulator capable of positive inspiratory pressure | <1% | 27 | $61.58 |
| 85379 | <1% | 182 | $56.42 | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 56 | $56.23 |
| 87077 | <1% | 197 | $47.91 | |
| 80320 | <1% | 484 | $36.70 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 89 | $36.21 |
| 82248 | <1% | 145 | $34.05 | |
| 71250 | <1% | 14 | $26.32 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 920 | $24.48 |
| A4663 | Blood pressure cuff only | <1% | 47 | $18.00 |
| J2704 | Injection, propofol, 10 mg | <1% | 191 | $11.03 |
| 81025 | <1% | 117 | $10.54 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 270 | $4.37 |
| 86901 | <1% | 358 | $4.17 | |
| 86900 | <1% | 358 | $4.12 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 176 | $3.98 |
| 82150 | <1% | 282 | $2.13 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 113 | $1.06 |
| A6196 | Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing | 0% | 60 | $0.00 |
| 94799 | 0% | 276 | $0.00 | |
| 87899 | 0% | 59 | $0.00 | |
| 94664 | 0% | 41 | $0.00 | |
| 80164 | 0% | 66 | $0.00 | |
| 84450 | 0% | 88 | $0.00 | |
| 84702 | 0% | 31 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 98 | $0.00 |
| 84100 | 0% | 50 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 126 | $0.00 |
| 80061 | Lipid panel | 0% | 14 | $0.00 |
| 84588 | 0% | 34 | $0.00 | |
| 97161 | 0% | 15 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 32 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 973 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 49 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 251 | $0.00 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 85 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 172 | $0.00 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 143 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 63 | $0.00 |
| 84132 | 0% | 179 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 39 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 26 | $0.00 |
| 97165 | 0% | 14 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 13 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCARMICHAEL, CRAIG (PRESIDENT)